Provectus Biopharmaceuticals, Inc.

Provectus Biopharmaceuticals launched VisiRose, a clinical-stage biotech focused on commercializing Rose Bengal Photodynamic Antimicrobial Therapy (RB PDAT) for eye infections using Provectus’s Rose Bengal Sodium (RBS). RB PDAT, developed with the University of Miami’s Bascom Palmer Eye Institute, treats infections caused by bacteria, fungi, and parasites, including multidrug-resistant organisms.